Table 4.
Age of onset | |||||
---|---|---|---|---|---|
|
|||||
≤3 mo | 4 to 12 mo | 13 mo to 5 yr | 6 to 12 yr | 13 to 17 yr | |
Patients (n) | 12 | 18 | 54 | 34 | 2 |
Causative genes, no (%) | WT1:1 (8.3%) | TRPC6:1 (de novel, 5.6%) | WT1:4 (7.4%) | ADCK4:5 (14.7%) | ADCK4:1 (50%) |
NPHS1:6 (50%) | WT1:2 (11.1%) | LMX1B: 2 (3.7%) | |||
ADCK4:1 (8.3%) | NPHS1:1 (5.6%) | NPHS2: 4 (7.4%) | |||
LAMB2:1 (8.3%) | PLCE1:1 (5.6%) | CUBN: 2 (3.7%) | |||
ADCK4:1 (1.9%) | |||||
SMARCAL1:1 (1.9%) |
mo, month; yr, year.